Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Social and clinical predictors associated with prolonged hospital stays for patients with severe exacerbation of chronic obstructive pulmonary disease.

Fernández-García S, Represas-Represas C, Ruano-Raviña A, Botana-Rial M, Mouronte-Roibas C, Ramos-Hernández C, Fernández Villar A.

Rev Clin Esp. 2019 Jun 14. pii: S0014-2565(19)30149-3. doi: 10.1016/j.rce.2019.05.003. [Epub ahead of print] English, Spanish.

PMID:
31208703
2.

Social Profile of Patients Admitted for COPD Exacerbations. A Gender Analysis.

Fernández-García S, Represas-Represas C, Ruano-Raviña A, Mosteiro-Añón M, Mouronte-Roibas C, Fernández-Villar A.

Arch Bronconeumol. 2019 Apr 11. pii: S0300-2896(19)30120-6. doi: 10.1016/j.arbres.2019.03.009. [Epub ahead of print] English, Spanish.

3.

Lung cancer and residential radon in never-smokers: A pooling study in the Northwest of Spain.

Lorenzo-González M, Ruano-Ravina A, Torres-Durán M, Kelsey KT, Provencio M, Parente-Lamelas I, Leiro-Fernández V, Vidal-García I, Castro-Añón O, Martínez C, Golpe-Gómez A, Zapata-Cachafeiro M, Piñeiro-Lamas M, Pérez-Ríos M, Abal-Arca J, Montero-Martínez C, Fernández-Villar A, Barros-Dios JM.

Environ Res. 2019 May;172:713-718. doi: 10.1016/j.envres.2019.03.011. Epub 2019 Mar 6.

PMID:
30903971
4.

Disentangling tobacco-related lung cancer-genome-wide interaction study of smoking behavior and non-small cell lung cancer risk.

Lorenzo-González M, Fernández-Villar A, Ruano-Ravina A.

J Thorac Dis. 2019 Jan;11(1):10-13. doi: 10.21037/jtd.2018.11.29. No abstract available.

5.

Predicting delays in lung cancer diagnosis and staging.

Leiro-Fernández V, Mouronte-Roibás C, García-Rodríguez E, Botana-Rial M, Ramos-Hernández C, Torres-Durán M, Ruano-Raviña A, Fernández-Villar A; Lung Cancer Group at the Álvaro Cunqueiro Hospital in Vigo.

Thorac Cancer. 2019 Feb;10(2):296-303. doi: 10.1111/1759-7714.12950. Epub 2019 Jan 3.

6.

Influence of the type of emphysema in the relationship between COPD and lung cancer.

Mouronte-Roibás C, Fernández-Villar A, Ruano-Raviña A, Ramos-Hernández C, Tilve-Gómez A, Rodríguez-Fernández P, Díaz ACC, Vázquez-Noguerol MG, Fernández-García S, Leiro-Fernández V.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 29;13:3563-3570. doi: 10.2147/COPD.S178109. eCollection 2018.

7.

Lung cancer and chronic obstructive pulmonary disease: understanding the complexity of carcinogenesis.

Mouronte-Roibás C, Ruano-Raviña A, Fernández-Villar A.

Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S214-S217. doi: 10.21037/tlcr.2018.08.11. No abstract available.

8.

[Available resources for the management of chronic obstructive pulmonary disease exacerbations in Spain].

Soler-Cataluña JJ, Fernández Villar A, Piñera Salmerón PL, Román-Rodríguez M, Huerta Hernández A, Roset Gamisans M.

Semergen. 2018 Oct;44(7):449-457. doi: 10.1016/j.semerg.2018.03.010. Epub 2018 Sep 8. Spanish.

PMID:
30206038
9.

Current Management of Pleural Effusion: Results of a National Survey.

Botana-Rial M, Núñez-Delgado M, Leiro-Fernández V, Fernández-Villar A.

Arch Bronconeumol. 2019 May;55(5):274-276. doi: 10.1016/j.arbres.2018.07.023. Epub 2018 Aug 16. English, Spanish. No abstract available.

10.

The 6-Minute Walk Test as a Tool for Determining Exercise Capacity and Prognosis in Patients with Silicosis.

Blanco Pérez JJ, Arnalich Montiel V, Salgado-Barreira Á, Alvarez Moure MA, Caldera Díaz AC, Cerdeira Dominguez L, Gonzalez Bello ME, Fernandez Villar A, González Barcala FJ.

Arch Bronconeumol. 2019 Feb;55(2):88-92. doi: 10.1016/j.arbres.2018.07.004. Epub 2018 Aug 9. English, Spanish.

11.

COPD prevalence and hospital admissions in Galicia (Spain). An analysis using the potential of new health information systems.

Barbosa-Lorenzo R, Ruano-Ravina A, Fernández-Villar A, López-Pardo E, Carballeira-Roca C, Barros-Dios JM.

Pulmonology. 2018 Nov - Dec;24(6):323-329. doi: 10.1016/j.pulmoe.2018.03.005. Epub 2018 May 5.

12.

Diagnostic Yield of Semi-rigid Thoracoscopy in the Molecular Characterization of Pulmonary Malignant Pleural Effusions.

Botana-Rial M, Mouronte-Roibás C, González-Piñeiro A, Fernández-Villar A.

Arch Bronconeumol. 2018 Sep;54(9):489-491. doi: 10.1016/j.arbres.2018.01.028. Epub 2018 Apr 5. English, Spanish. No abstract available.

13.

HypAir FeNO: an electrochemical sensor.

Ramos Hernández C, Núñez Fernández M, Mouronte-Roibas C, Mosteiro Añon M, Fernández-Villar A.

Eur Respir J. 2018 Apr 4;51(4). pii: 1800164. doi: 10.1183/13993003.00164-2018. Print 2018 Apr. No abstract available.

PMID:
29618604
14.

Chronic Obstructive Pulmonary Disease in Lung Cancer Patients: Prevalence, Underdiagnosis, and Clinical Characterization.

Mouronte-Roibás C, Leiro-Fernández V, Ruano-Raviña A, Ramos-Hernández C, Abal-Arca J, Parente-Lamelas I, Botana-Rial M, Priegue-Carrera A, Fernández-Villar A.

Respiration. 2018;95(6):414-421. doi: 10.1159/000487243. Epub 2018 Mar 27.

PMID:
29587299
15.

Reliability and usefulness of spirometry performed during admission for COPD exacerbation.

Fernández-Villar A, Represas-Represas C, Mouronte-Roibás C, Ramos-Hernández C, Priegue-Carrera A, Fernández-García S, López-Campos JL.

PLoS One. 2018 Mar 26;13(3):e0194983. doi: 10.1371/journal.pone.0194983. eCollection 2018.

16.

Validation of the portable Air-Smart Spirometer.

Ramos Hernández C, Núñez Fernández M, Pallares Sanmartín A, Mouronte Roibas C, Cerdeira Domínguez L, Botana Rial MI, Blanco Cid N, Fernández Villar A.

PLoS One. 2018 Feb 23;13(2):e0192789. doi: 10.1371/journal.pone.0192789. eCollection 2018.

17.

Lung Cancer Unrelated to Smoking.

Torres-Durán M, Fernández-Villar A, Ruano-Raviña A.

Arch Bronconeumol. 2018 Jun;54(6):301-302. doi: 10.1016/j.arbres.2018.01.001. Epub 2018 Feb 13. English, Spanish. No abstract available.

18.

Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.

Blanco-Prieto S, Barcia-Castro L, Páez de la Cadena M, Rodríguez-Berrocal FJ, Vázquez-Iglesias L, Botana-Rial MI, Fernández-Villar A, De Chiara L.

BMC Cancer. 2017 Dec 5;17(1):823. doi: 10.1186/s12885-017-3842-z.

19.

Evaluation of clinical variables according to follow-up times in COPD: results from ON-SINT cohort.

Luis López-Campos J, Fernández-Villar A, Represas Represas C, Marín Barrera L, Botana Rial M, López Ramírez C, Casamor R.

Eur Clin Respir J. 2017 Nov 2;4(1):1394132. doi: 10.1080/20018525.2017.1394132. eCollection 2017.

20.

Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.

Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, de Lucas-Ramos P, Marin JM, Martinez C, Mir I, Soriano JB, de Torres JP, Agusti A, Atalay NB, Billington J, Boutou AK, Brighenti-Zogg S, Chaplin E, Coster S, Dodd JW, Dürr S, Fernandez-Villar A, Groenen MTJ, Guimarães M, Hejduk K, Higgins V, Hopkinson NS, Horita N, Houben-Wilke S, Janssen DJA, Jehn M, Joerres R, Karch A, Kelly JL, Kim YI, Kimura H, Koblizek V, Kocks JH, Kon SSC, Kwon N, Ladeira I, Lee SD, Leuppi JD, Locantore N, Lopez-Campos JL, D-C Man W, Maricic L, Mendoza L, Miedinger D, Mihaltan F, Minami S, van der Molen T, Murrells TJ, Nakken N, Nishijima Y, Norman IJ, Novotna B, O'Donnell DE, Ogata Y, Pereira ED, Piercy J, Price D, Pothirat C, Raghavan N, Ringbaek T, Sajkov D, Sigari N, Singh S, Small M, da Silva GF, Tanner RJ, Tsiligianni IG, Tulek B, Tzanakis N, Vanfleteren LEGW, Watz H, Webb KA, Wouters EFM, Xie GG, Yoshikawa M, Spruit MA.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003. Review.

21.

Alcohol consumption and lung cancer risk in never smokers: a pooled analysis of case-control studies.

García Lavandeira JA, Ruano-Ravina A, Kelsey KT, Torres-Durán M, Parente-Lamelas I, Leiro-Fernández V, Zapata M, Abal-Arca J, Vidal-García I, Montero-Martínez C, Amenedo M, Castro-Añón O, Golpe-Gómez A, Guzmán-Taveras R, Martínez C, Provencio M, Mejuto-Martí MJ, García-García S, Fernández-Villar A, Piñeiro M, Barros-Dios JM.

Eur J Public Health. 2018 Jun 1;28(3):521-527. doi: 10.1093/eurpub/ckx196.

PMID:
29140412
22.

Action levels for indoor radon: different risks for the same lung carcinogen?

Ruano-Ravina A, Kelsey KT, Fernández-Villar A, Barros-Dios JM.

Eur Respir J. 2017 Nov 9;50(5). pii: 1701609. doi: 10.1183/13993003.01609-2017. Print 2017 Nov. No abstract available.

23.

Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study.

Torres-Durán M, Ruano-Ravina A, Kelsey KT, Parente-Lamelas I, Leiro-Fernández V, Abdulkader I, Provencio M, Abal-Arca J, Castro-Añón O, Montero-Martínez C, Vidal-García I, Amenedo M, Golpe-Gómez A, Martínez C, Guzmán-Taveras R, Mejuto-Martí MJ, Fernández-Villar A, Barros-Dios JM.

Cancer Lett. 2017 Dec 28;411:130-135. doi: 10.1016/j.canlet.2017.09.042. Epub 2017 Oct 5.

PMID:
28987389
24.

Small Cell Lung Cancer. Methodology and Preliminary Results of the SMALL CELL Study.

Rodríguez-Martínez Á, Ruano-Ravina A, Torres-Durán M, Vidal-García I, Leiro-Fernández V, Hernández-Hernández J, García-García S, Provencio M, Castro-Añón O, Parente-Lamelas I, Abdulkader I, Abal-Arca J, Montero-Martínez C, Amenedo M, Guzmán-Taveras R, Fernández-Villar A, Barros-Dios JM.

Arch Bronconeumol. 2017 Dec;53(12):675-681. doi: 10.1016/j.arbres.2017.04.016. Epub 2017 Jun 15. English, Spanish.

25.

Overdiagnosis of COPD: precise definitions and proposals for improvement.

Fernández-Villar A, Soriano JB, López-Campos JL.

Br J Gen Pract. 2017 Apr;67(657):183-184. doi: 10.3399/bjgp17X690389. No abstract available.

26.

Deletion of GSTM1 and GSTT1 genes and lung cancer survival: a systematic review.

Ramos Hernández C, Mouronte-Roibás C, Barros-Dios JM, Fernández-Villar A, Ruano-Ravina A.

Tumori. 2017 Jul 31;103(4):338-344. doi: 10.5301/tj.5000621. Epub 2017 Mar 18. Review.

PMID:
28315511
27.

The importance of rural living and sex in exposure to biomass smoke.

Lopez-Campos JL, Fernandez Villar A, Casamor R.

Arch Bronconeumol. 2017 May;53(5):290. doi: 10.1016/j.arbres.2017.01.005. Epub 2017 Feb 24. English, Spanish. No abstract available.

28.

Residential Radon and Risk of Lung Cancer in Never-Smokers.

Ruano-Ravina A, Fernández-Villar A, Barros-Dios JM.

Arch Bronconeumol. 2017 Sep;53(9):475-476. doi: 10.1016/j.arbres.2017.01.004. Epub 2017 Feb 22. English, Spanish. No abstract available.

29.

Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units.

Blanco-Prieto S, De Chiara L, Rodríguez-Girondo M, Vázquez-Iglesias L, Rodríguez-Berrocal FJ, Fernández-Villar A, Botana-Rial MI, de la Cadena MP.

Sci Rep. 2017 Jan 24;7:41151. doi: 10.1038/srep41151.

30.

New Uses for Old Biomarkers in chronic obstructive pulmonar disease and Obstructive Sleep Apnea?

Represas C, Botana M, Fernández-Villar A.

Arch Bronconeumol. 2017 Mar;53(3):93-94. doi: 10.1016/j.arbres.2016.11.015. Epub 2017 Jan 13. English, Spanish. No abstract available.

31.

Update in the extraction of airway foreign bodies in adults.

Blanco Ramos M, Botana-Rial M, García-Fontán E, Fernández-Villar A, Gallas Torreira M.

J Thorac Dis. 2016 Nov;8(11):3452-3456. doi: 10.21037/jtd.2016.11.32. Review.

32.

Development of Aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp.

Barberán J, García-Pérez FJ, Villena V, Fernández-Villar A, Malmierca E, Salas C, Giménez MJ, Granizo JJ, Aguilar L; working group on Infectious Diseases from the Spanish Society of Internal Medicine.

BMC Infect Dis. 2017 Jan 6;17(1):34. doi: 10.1186/s12879-016-2143-5.

33.

Validity Study of Catalan, Galician and Basque Language Versions of the COPD Assessment Test and Equivalence With the Spanish Version.

Agustí A, Fernández-Villar A, Capelastegui A, García-Losa M, Velasco B, Sánchez G.

Arch Bronconeumol. 2017 Jun;53(6):311-317. doi: 10.1016/j.arbres.2016.10.003. Epub 2016 Dec 13. English, Spanish.

34.

FDG-PET parameters predicting mediastinal malignancy in lung cancer.

Serra Fortuny M, Gallego M, Berna L, Montón C, Vigil L, Masdeu MJ, Fernández-Villar A, Botana MI, Cordovilla R, García-Luján R, Cases E, Monsó E.

BMC Pulm Med. 2016 Dec 8;16(1):177.

35.

The importance of units specialising in pleural disease for postgraduate training.

Botana-Rial M, Fernández-Villar A.

Rev Clin Esp. 2016 Dec;216(9):481-482. doi: 10.1016/j.rce.2016.10.002. English, Spanish. No abstract available.

PMID:
27908379
36.

Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid.

Vázquez-Iglesias L, Casado-Rey P, Botana-Rial M, Andrade-Olivié MA, Rodriguez-Berrocal FJ, Páez de la Cadena M, Fernández-Villar A.

Clin Chem Lab Med. 2017 Jul 26;55(8):e172-e174. doi: 10.1515/cclm-2016-0884. No abstract available.

PMID:
27898399
37.

Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases.

Ruano-Ravina A, Torres-Durán M, Kelsey KT, Parente-Lamelas I, Leiro-Fernández V, Abdulkader I, Abal-Arca J, Montero-Martínez C, Vidal-García I, Amenedo M, Castro-Añón O, Golpe-Gómez A, González-Barcala J, Martínez C, Guzmán-Taveras R, Provencio M, Mejuto-Martí MJ, Fernández-Villar A, Barros-Dios JM.

Eur Respir J. 2016 Nov;48(5):1462-1470. doi: 10.1183/13993003.00407-2016. Epub 2016 Oct 6.

38.

Residential radon and COPD. An ecological study in Galicia, Spain.

Barbosa-Lorenzo R, Ruano-Ravina A, Ramis R, Aragonés N, Kelsey KT, Carballeira-Roca C, Fernández-Villar A, López-Abente G, Barros-Dios JM.

Int J Radiat Biol. 2017 Feb;93(2):222-230. doi: 10.1080/09553002.2017.1238526. Epub 2016 Nov 17.

PMID:
27778529
39.

COPD, emphysema and the onset of lung cancer. A systematic review.

Mouronte-Roibás C, Leiro-Fernández V, Fernández-Villar A, Botana-Rial M, Ramos-Hernández C, Ruano-Ravina A.

Cancer Lett. 2016 Nov 28;382(2):240-244. doi: 10.1016/j.canlet.2016.09.002. Epub 2016 Sep 22. Review.

PMID:
27666776
40.

Reconsidering lung cancer screening: is biannual screening possible?

Ruano-Ravina A, Fernandez-Villar A, Provencio-Pulla M.

J Thorac Dis. 2016 Sep;8(9):2372-2375. No abstract available.

41.

Spanish experience on the design of radon surveys based on the use of geogenic information.

Sainz Fernández C, Quindós Poncela LS, Fernández Villar A, Fuente Merino I, Gutierrez-Villanueva JL, Celaya González S, Quindós López L, Quindós López J, Fernández E, Remondo Tejerina J, Martín Matarranz JL, García Talavera M.

J Environ Radioact. 2017 Jan;166(Pt 2):390-397. doi: 10.1016/j.jenvrad.2016.07.007. Epub 2016 Sep 25.

PMID:
27681529
42.

A Pseudo-Outbreak of Pseudomonas putida and Stenotrophomonas maltophilia in a Bronchoscopy Unit.

Botana-Rial M, Leiro-Fernández V, Núñez-Delgado M, Álvarez-Fernández M, Otero-Fernández S, Bello-Rodríguez H, Vilariño-Pombo C, Fernández-Villar A.

Respiration. 2016;92(4):274-278. Epub 2016 Sep 15.

43.

HLA-DQ B1*0201 and A1*0102 Alleles Are Not Responsible for Antituberculosis Drug-Induced Hepatotoxicity Risk in Spanish Population.

Leiro-Fernández V, Valverde D, Vázquez-Gallardo R, Constenla-Caramés L, Del Campo-Pérez V, Fernández-Villar A.

Front Med (Lausanne). 2016 Aug 22;3:34. doi: 10.3389/fmed.2016.00034. eCollection 2016.

44.

Residential Radon: The Neglected Risk Factor in Lung Cancer Risk Scores.

Torres-Duran M, Fernandez-Villar A, Barros-Dios JM, Ruano-Ravina A.

J Thorac Oncol. 2016 Sep;11(9):1384-6. doi: 10.1016/j.jtho.2016.05.018.

45.

Lichtheimia ramosa: A Fatal Case of Mucormycosis.

Mouronte-Roibás C, Leiro-Fernández V, Botana-Rial M, Ramos-Hernández C, Lago-Preciado G, Fiaño-Valverde C, Fernández-Villar A.

Can Respir J. 2016;2016:2178218. doi: 10.1155/2016/2178218. Epub 2016 Mar 29.

46.

Occupational and Biomass Exposure in Chronic Obstructive Pulmonary Disease: Results of a Cross-Sectional Analysis of the On-Sint Study.

López-Campos JL, Fernández-Villar A, Calero-Acuña C, Represas-Represas C, López-Ramírez C, Fernández VL, Casamor R; en nombre de los investigadores del estudio On-Sint.

Arch Bronconeumol. 2017 Jan;53(1):7-12. doi: 10.1016/j.arbres.2016.04.013. Epub 2016 Jul 16. English, Spanish.

47.

Efficacy of Double Bronchodilation (LABA+LAMA) in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Lung Cancer.

Leiro-Fernández V, Priegue Carrera A, Fernández-Villar A.

Arch Bronconeumol. 2016 Dec;52(12):622-623. doi: 10.1016/j.arbres.2016.05.012. Epub 2016 Jun 29. English, Spanish. No abstract available.

48.

Spatiotemporal distribution of δ(13)CCO2 in a shallow cave and its potential use as indicator of anthropic pressure.

Gázquez F, Quindós-Poncela L, Sainz-Fernández C, Fernández-Villar A, Fuente-Merino I, Celaya-Gonzalez S.

J Environ Manage. 2016 Sep 15;180:421-32. doi: 10.1016/j.jenvman.2016.05.078. Epub 2016 Jun 3.

PMID:
27266647
49.

[Cons: Lung cancer screening with low-dose computed tomography].

Ruano-Ravina A, Fernández-Villar A, Provencio-Pulla M.

Gac Sanit. 2016 Sep-Oct;30(5):383-5. doi: 10.1016/j.gaceta.2016.03.003. Epub 2016 Apr 27. Spanish. No abstract available.

50.

Screening for Chronic Obstructive Pulmonary Disease: Validity and Reliability of a Portable Device in Non-Specialized Healthcare Settings.

Represas-Represas C, Fernández-Villar A, Ruano-Raviña A, Priegue-Carrera A, Botana-Rial M; study group of “Validity of COPD-6 in non-specialized healthcare settings”.

PLoS One. 2016 Jan 4;11(1):e0145571. doi: 10.1371/journal.pone.0145571. eCollection 2016.

Supplemental Content

Loading ...
Support Center